NCT04418440View on ClinicalTrials.gov

Nutritional Treatment for the Amelioration of Traumatic Brain Injury

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Traumatic Brain Injury
Interventions
DIETARY_SUPPLEMENT

Souvenaid oral nutritional supplement (Nutricia)

Daily dose of a commercially available oral nutritional supplement based around the active compound recipe Fortasyn Connect, produced by Nutricia, Danone.

Trial Locations (1)

E1 1FR

Bart Health, Royal London Hospital, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT04418440 - Nutritional Treatment for the Amelioration of Traumatic Brain Injury | Biotech Hunter | Biotech Hunter